Portfolio company
Cellvoyant
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Cellvoyant develops AI-powered imaging platforms and services to predict and optimise stem cell differentiation for biotechnology and pharmaceutical organisations developing cell-based therapies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Tolemy Bio
This company develops an AI platform to model and optimise cellular behaviour for biotechnology and pharmaceutical organisations developing advanced therapies.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Stately Bio
This company develops machine learning imaging platforms and stem cell-derived therapies for biopharmaceutical researchers and clinical institutions.
Cellular Intelligence
This company develops artificial intelligence foundation models to predict cell signaling and design cell therapies for pharmaceutical companies and clinical researchers.
Cellino
The company develops an autonomous biomanufacturing platform to produce personalised stem cell therapies for patients with chronic degenerative diseases.
CellRep
CellRep develops an artificial intelligence platform discovering small molecules that rejuvenate immune cells for developers of cell therapies and regenerative medicine.
CellType
This company develops artificial intelligence agents and biological foundation models to simulate human biology for pharmaceutical and biotechnology drug discovery teams.
Deepcell
Deepcell develops an artificial intelligence-powered imaging and sorting platform for single-cell morphology analysis, serving life sciences researchers, diagnostic labs, and pharmaceutical companies.
